Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy (how well the drug works), safety, and
side effects of paliperidone palmitate compared to placebo in the treatment of the symptoms
of schizophrenia in adults. The placebo used in this study was a nutritional substance known
as 20% Intralipid emulsion given to patients requiring intravenous feedings.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.